About Parkinson’s Disease


Parkinson's disease is a progressive neurodegenerative disorder that results in decreased levels of dopamine in the striatum. The cause of Parkinson’s disease remains unknown.

Symptoms:

  • Parkinson’s disease leads to multiple symptoms including rigidity, slowing of movement, and resting tremor.

Epidemiology:

  • Approximately one percent of adults over the age of 60 are affected by Parkinson’s disease. There are between 7-10 million patients worldwide.

Treatment:

  • Levodopa, an oral medication, treats patients in the earlier stages of the disease but has proven to have waning efficacy over time.

  • Some patients with advanced disease undergo a procedure called deep brain stimulation (DBS), in which a device is implanted in your brain and chest to provide electrical impulses to the brain

  • Currently there are no therapies available that slow or reverse the progression of Parkinson’s disease.

 

Some organizations that offer information, resources and support for patients with Parkinson’s disease include:

AXOVANT GENE THERAPIES

Eleven Times Square, 33rd Floor
New York, NY 10036
United States

+1-833-AXOVANT (1-833-296-8268)

  • Axovant Gene Therapies LinkedIn
  • Axovant Gene Therapies Twitter
  • Axovant Gene Therapies Facebook

AXOVANT SCIENCES GMBH

Viaduktstrasse 8
4051 Basel
Switzerland